AUA 2022 Annual Meeting

Conference Coverage

PSA Screening for Prostate Cancer Beneficial, Especially for Black Men

In all studied scenarios, PSA screening appeared more favorable for Black men than for the general population.

Ureteral Stone Expulsion Rate Higher With Combination Treatment

Quick discharge of residual stones from the urinary tract is warranted after lithotripsy.

Active Surveillance Rate for Low-Risk Prostate Cancer Is Rising

Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.

Robotic Partial Nephrectomy Outcomes Worse When PSMs Are Present

Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.

Neoadjuvant Axitinib May Enable Partial Nephrectomy in Complex Renal Tumors

An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.

Study: Confirmatory Prostate Biopsies Still Needed Despite Upfront MRI

New findings challenge recommendations from the European Association of Urology.

Kidney Transplantation From COVID-19 Positive Donors Is Safe

Among donor selection criteria, COVID-19-positive deceased donors could not have significant primary or secondary kidney injury.

Prostate Cancer Upgrading on AS Linked to Perineural Invasion

The presence of perineural invasion in a prostate biopsy has important implications for active surveillance.

Erectile Dysfunction Ups Risk for Major Adverse Cardiovascular Events

Investigators urge health care professionals who manage patients with ED to discuss the risk of future cardiovascular disease.

Prostate Cancer Upgrading Risk in Active Surveillance Does Not Differ by Race

Active surveillance appears to be a safe treatment option for low- and very low-risk prostate cancer, regardless of race, according to investigators.

Use of 5-ARIs May Decrease Bladder Cancer Risk

A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.

Predictors of Recurrence After RNU for Low-Grade UTUC

Findings may inform surveillance strategies and improve treatment outcomes.

Negative MRI in Active Surveillance Often Predicts Stable Prostate Cancer

Some patients with a negative mpMRI while on prostate cancer active surveillance may be able to defer biopsy, according to investigators.

UTUC in Octogenarians Frequently Managed Without Surgery

Approximately one-quarter of patients aged 80 years or older with upper tract urothelial carcinoma are managed expectantly, data show.

Overactive Bladder in Men Linked to Excessive Visceral Fat

In a Japanese study, men with vs without OAB had a significantly higher visceral fat area and visceral fat volume.

COVID-19 Infection Ups Risk for New or Worsening OAB Symptoms

COVID-19-associated cystitis appears to be a common problem among infected individuals.

Post-RC Radiation Does Not Up Survival in Locally Advanced Bladder Cancer

Further studies are needed to evaluate oncologic outcomes after postoperative radiation therapy.

Morbid Obesity Ups Odds of Multiple Urologic Conditions

Efforts to reduce obesity may cut the prevalence of these urological conditions.

Study: Alternative to BCG in High-Risk NMIBC Shows Excellent Efficacy

Investigators report a 24-month recurrence-free survival rate of 82% with the use of intravesical gemcitabine/docetaxel following complete transurethral resection of bladder tumor.

PSA Bounce vs Biochemical Recurrence After Prostate Cancer SBRT Probed

Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer.